Search Results for “” – Page 42 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Study Design

1276 Publications found

Costs of Point-of-Care Viral Load Testing for Adults and Children Living with HIV in Kenya.

b

Diagnostics (Basel, Switzerland)

January 19, 2021

p HIV POCT

c Economics Observational
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.

b

American journal of respiratory and critical care medicine

January 15, 2021

p Antibiotic Guidance

c Change patient management Clinical outcomes Highlighted Operational efficiencies RCT
Targeting G1/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor-based regimens.

b

JCI insight

January 11, 2021

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
Economic evaluation of alternative testing regimes and settings to detect undiagnosed HIV in Australia.

b

BMC health services research

January 7, 2021

p HIV POCT

c Economics Model
A Phase II Trial of Osimertinib as the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1.

b

Cancer research and treatment

January 1, 2021

p Cancer

c Change patient management Clinical outcomes Observational
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.

b

Intensive care medicine

January 1, 2021

p Viscoelastic Testing

c Change patient management Clinical outcomes RCT
Implementation of a Molecular Tumor Registry to Support the Adoption of Precision Oncology Within an Academic Medical Center: The Duke University Experience.

b

JCO precision oncology

January 1, 2021

p Cancer

c Change patient management Observational
Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina.

b

Ecancermedicalscience

January 1, 2021

p Cancer

c Change patient management Observational
EGFR mutation-guided use of afatinib, erlotinib and gefitinib for advanced non-small-cell lung cancer in Hong Kong – A cost-effectiveness analysis.

b

PloS one

January 1, 2021

p Cancer

c Economics Model
Quality of Life Is Associated with Cardiac Biomarkers, Echocardiographic Indices, and Mortality in CKD Stage 4-5 Patients Not on Dialysis.

b

Blood purification

January 1, 2021

p Cardiovascular Disease

c Clinical outcomes Observational Patient-centeredness